Paragon Care Ltd (AU:PGC) — Market Cap & Net Worth
Market Cap & Net Worth: Paragon Care Ltd (PGC)
Paragon Care Ltd (AU:PGC) has a market capitalization of $181.54 Million (AU$256.57 Million) as of May 5, 2026. Listed on the AU stock exchange, this Australia-based company holds position #16916 globally and #490 in its home market, demonstrating a -3.13% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Paragon Care Ltd's stock price AU$0.16 by its total outstanding shares 1655305389 (1.66 Billion). Analyse cash flow conversion of Paragon Care Ltd to see how efficiently the company converts income to cash.
Paragon Care Ltd Market Cap History: 2015 to 2026
Paragon Care Ltd's market capitalization history from 2015 to 2026. Data shows change from $611.38 Million to $181.54 Million (-9.84% CAGR).
Paragon Care Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Paragon Care Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Paragon Care Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
12.24x
Paragon Care Ltd's market cap is 12.24 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $750.41 Million | $93.38 Million | $7.53 Million | 8.04x | 99.65x |
| 2017 | $768.68 Million | $117.19 Million | $10.17 Million | 6.56x | 75.55x |
| 2018 | $649.57 Million | $117.20 Million | $10.95 Million | 5.54x | 59.32x |
| 2019 | $457.84 Million | $236.01 Million | $8.86 Million | 1.94x | 51.66x |
| 2020 | $234.13 Million | $231.69 Million | -$77.27 Million | 1.01x | N/A |
| 2021 | $386.39 Million | $235.84 Million | $8.28 Million | 1.64x | 46.67x |
| 2022 | $347.74 Million | $237.62 Million | $6.63 Million | 1.46x | 52.42x |
| 2023 | $263.53 Million | $307.63 Million | $12.80 Million | 0.86x | 20.59x |
| 2024 | $562.19 Million | $2.97 Billion | $8.38 Million | 0.19x | 67.08x |
| 2025 | $251.82 Million | $3.61 Billion | $20.57 Million | 0.07x | 12.24x |
Competitor Companies of PGC by Market Capitalization
Companies near Paragon Care Ltd in the global market cap rankings as of May 5, 2026.
Key companies related to Paragon Care Ltd by market ranking:
- McKesson Corporation (NYSE:MCK): Ranked #248 globally with a market cap of $98.95 Billion USD.
- Cencora Inc. (NYSE:COR): Ranked #439 globally with a market cap of $59.07 Billion USD.
- Cardinal Health Inc (NYSE:CAH): Ranked #561 globally with a market cap of $46.37 Billion USD.
- Sigma Healthcare Ltd (AU:SIG): Ranked #1108 globally with a market cap of $23.12 Billion USD ( AU$32.67 Billion AUD).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #248 | McKesson Corporation | NYSE:MCK | $98.95 Billion | $807.85 |
| #439 | Cencora Inc. | NYSE:COR | $59.07 Billion | $303.66 |
| #561 | Cardinal Health Inc | NYSE:CAH | $46.37 Billion | $197.06 |
| #1108 | Sigma Healthcare Ltd | AU:SIG | $23.12 Billion | AU$2.83 |
Paragon Care Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Paragon Care Ltd's market cap moved from $611.38 Million to $ 181.54 Million, with a yearly change of -9.84%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$181.54 Million | -27.91% |
| 2025 | AU$251.82 Million | -55.21% |
| 2024 | AU$562.19 Million | +113.33% |
| 2023 | AU$263.53 Million | -24.22% |
| 2022 | AU$347.74 Million | -10.00% |
| 2021 | AU$386.39 Million | +65.03% |
| 2020 | AU$234.13 Million | -48.86% |
| 2019 | AU$457.84 Million | -29.52% |
| 2018 | AU$649.57 Million | -15.50% |
| 2017 | AU$768.68 Million | +2.43% |
| 2016 | AU$750.41 Million | +22.74% |
| 2015 | AU$611.38 Million | -- |
End of Day Market Cap According to Different Sources
On May 5th, 2026 the market cap of Paragon Care Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $181.54 Million USD |
| MoneyControl | $181.54 Million USD |
| MarketWatch | $181.54 Million USD |
| marketcap.company | $181.54 Million USD |
| Reuters | $181.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Paragon Care Ltd
Paragon Care Limited distributes medical equipment, devices, and consumable products in Australia, New Zealand, and Asia. The company designs, manufactures, and distributes reagent red blood cells, monoclonal blood grouping reagents, and ancillary products for immunohematology laboratories; offers ophthalmology and optometry, neonatal vision screening solutions, and procedural kits. It also provi… Read more